The global Nucleic Acid-based Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid-based Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid-based Drugs.

Report Scope

The Nucleic Acid-based Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid-based Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nucleic Acid-based Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nucleic Acid-based Drugs Market Report

Report Metric	Details
Report Name	Nucleic Acid-based Drugs Market
CAGR	5%
Segment by Type	ASO mRNA siRNA miRNA saRNA Aptamer
Segment by Application	Genetic Disease Cancer Cardiovascular Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, BioNTech, Moderna Therapeutics, CureVac, Alnylam Pharmaceuticals, Regulus Therapeutics, Miragen Therapeutics, Mina Therapeutics, NeXstar Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid-based Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nucleic Acid-based Drugs Market report?

Ans: The main players in the Nucleic Acid-based Drugs Market are Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, BioNTech, Moderna Therapeutics, CureVac, Alnylam Pharmaceuticals, Regulus Therapeutics, Miragen Therapeutics, Mina Therapeutics, NeXstar Pharmaceuticals

What are the Application segmentation covered in the Nucleic Acid-based Drugs Market report?

Ans: The Applications covered in the Nucleic Acid-based Drugs Market report are Genetic Disease, Cancer, Cardiovascular Diseases, Other

What are the Type segmentation covered in the Nucleic Acid-based Drugs Market report?

Ans: The Types covered in the Nucleic Acid-based Drugs Market report are ASO, mRNA, siRNA, miRNA, saRNA, Aptamer

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nucleic Acid-based Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 ASO

1.2.3 mRNA

1.2.4 siRNA

1.2.5 miRNA

1.2.6 saRNA

1.2.7 Aptamer

1.3 Market by Application

1.3.1 Global Nucleic Acid-based Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Genetic Disease

1.3.3 Cancer

1.3.4 Cardiovascular Diseases

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nucleic Acid-based Drugs Market Perspective (2019-2030)

2.2 Nucleic Acid-based Drugs Growth Trends by Region

2.2.1 Global Nucleic Acid-based Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Nucleic Acid-based Drugs Historic Market Size by Region (2019-2024)

2.2.3 Nucleic Acid-based Drugs Forecasted Market Size by Region (2025-2030)

2.3 Nucleic Acid-based Drugs Market Dynamics

2.3.1 Nucleic Acid-based Drugs Industry Trends

2.3.2 Nucleic Acid-based Drugs Market Drivers

2.3.3 Nucleic Acid-based Drugs Market Challenges

2.3.4 Nucleic Acid-based Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nucleic Acid-based Drugs Players by Revenue

3.1.1 Global Top Nucleic Acid-based Drugs Players by Revenue (2019-2024)

3.1.2 Global Nucleic Acid-based Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Nucleic Acid-based Drugs Revenue

3.4 Global Nucleic Acid-based Drugs Market Concentration Ratio

3.4.1 Global Nucleic Acid-based Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Drugs Revenue in 2023

3.5 Nucleic Acid-based Drugs Key Players Head office and Area Served

3.6 Key Players Nucleic Acid-based Drugs Product Solution and Service

3.7 Date of Enter into Nucleic Acid-based Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid-based Drugs Breakdown Data by Type

4.1 Global Nucleic Acid-based Drugs Historic Market Size by Type (2019-2024)

4.2 Global Nucleic Acid-based Drugs Forecasted Market Size by Type (2025-2030)

5 Nucleic Acid-based Drugs Breakdown Data by Application

5.1 Global Nucleic Acid-based Drugs Historic Market Size by Application (2019-2024)

5.2 Global Nucleic Acid-based Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Nucleic Acid-based Drugs Market Size (2019-2030)

6.2 North America Nucleic Acid-based Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Nucleic Acid-based Drugs Market Size by Country (2019-2024)

6.4 North America Nucleic Acid-based Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nucleic Acid-based Drugs Market Size (2019-2030)

7.2 Europe Nucleic Acid-based Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Nucleic Acid-based Drugs Market Size by Country (2019-2024)

7.4 Europe Nucleic Acid-based Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nucleic Acid-based Drugs Market Size (2019-2030)

8.2 Asia-Pacific Nucleic Acid-based Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Nucleic Acid-based Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Nucleic Acid-based Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nucleic Acid-based Drugs Market Size (2019-2030)

9.2 Latin America Nucleic Acid-based Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Nucleic Acid-based Drugs Market Size by Country (2019-2024)

9.4 Latin America Nucleic Acid-based Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nucleic Acid-based Drugs Market Size (2019-2030)

10.2 Middle East & Africa Nucleic Acid-based Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Nucleic Acid-based Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Nucleic Acid-based Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ionis Pharmaceuticals

11.1.1 Ionis Pharmaceuticals Company Detail

11.1.2 Ionis Pharmaceuticals Business Overview

11.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Introduction

11.1.4 Ionis Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.1.5 Ionis Pharmaceuticals Recent Development

11.2 Sarepta Therapeutics

11.2.1 Sarepta Therapeutics Company Detail

11.2.2 Sarepta Therapeutics Business Overview

11.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Introduction

11.2.4 Sarepta Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.2.5 Sarepta Therapeutics Recent Development

11.3 Nippon Shinyaku

11.3.1 Nippon Shinyaku Company Detail

11.3.2 Nippon Shinyaku Business Overview

11.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Introduction

11.3.4 Nippon Shinyaku Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.3.5 Nippon Shinyaku Recent Development

11.4 BioNTech

11.4.1 BioNTech Company Detail

11.4.2 BioNTech Business Overview

11.4.3 BioNTech Nucleic Acid-based Drugs Introduction

11.4.4 BioNTech Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.4.5 BioNTech Recent Development

11.5 Moderna Therapeutics

11.5.1 Moderna Therapeutics Company Detail

11.5.2 Moderna Therapeutics Business Overview

11.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Introduction

11.5.4 Moderna Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.5.5 Moderna Therapeutics Recent Development

11.6 CureVac

11.6.1 CureVac Company Detail

11.6.2 CureVac Business Overview

11.6.3 CureVac Nucleic Acid-based Drugs Introduction

11.6.4 CureVac Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.6.5 CureVac Recent Development

11.7 Alnylam Pharmaceuticals

11.7.1 Alnylam Pharmaceuticals Company Detail

11.7.2 Alnylam Pharmaceuticals Business Overview

11.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Introduction

11.7.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.7.5 Alnylam Pharmaceuticals Recent Development

11.8 Regulus Therapeutics

11.8.1 Regulus Therapeutics Company Detail

11.8.2 Regulus Therapeutics Business Overview

11.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Introduction

11.8.4 Regulus Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.8.5 Regulus Therapeutics Recent Development

11.9 Miragen Therapeutics

11.9.1 Miragen Therapeutics Company Detail

11.9.2 Miragen Therapeutics Business Overview

11.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Introduction

11.9.4 Miragen Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.9.5 Miragen Therapeutics Recent Development

11.10 Mina Therapeutics

11.10.1 Mina Therapeutics Company Detail

11.10.2 Mina Therapeutics Business Overview

11.10.3 Mina Therapeutics Nucleic Acid-based Drugs Introduction

11.10.4 Mina Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.10.5 Mina Therapeutics Recent Development

11.11 NeXstar Pharmaceuticals

11.11.1 NeXstar Pharmaceuticals Company Detail

11.11.2 NeXstar Pharmaceuticals Business Overview

11.11.3 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Introduction

11.11.4 NeXstar Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2019-2024)

11.11.5 NeXstar Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Ionis Pharmaceuticals

Alnylam Pharmaceuticals

Regulus Therapeutics

miRagen Therapeutics

Mina Therapeutics

NeXstar Pharmaceuticals

List of Tables

Table 1. Global Nucleic Acid-based Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of ASO

Table 3. Key Players of mRNA

Table 4. Key Players of siRNA

Table 5. Key Players of miRNA

Table 6. Key Players of saRNA

Table 7. Key Players of Aptamer

Table 8. Global Nucleic Acid-based Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Nucleic Acid-based Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Nucleic Acid-based Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Nucleic Acid-based Drugs Market Share by Region (2019-2024)

Table 12. Global Nucleic Acid-based Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Nucleic Acid-based Drugs Market Share by Region (2025-2030)

Table 14. Nucleic Acid-based Drugs Market Trends

Table 15. Nucleic Acid-based Drugs Market Drivers

Table 16. Nucleic Acid-based Drugs Market Challenges

Table 17. Nucleic Acid-based Drugs Market Restraints

Table 18. Global Nucleic Acid-based Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Nucleic Acid-based Drugs Market Share by Players (2019-2024)

Table 20. Global Top Nucleic Acid-based Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Drugs as of 2023)

Table 21. Ranking of Global Top Nucleic Acid-based Drugs Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Nucleic Acid-based Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Nucleic Acid-based Drugs Product Solution and Service

Table 25. Date of Enter into Nucleic Acid-based Drugs Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Nucleic Acid-based Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Nucleic Acid-based Drugs Revenue Market Share by Type (2019-2024)

Table 29. Global Nucleic Acid-based Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Nucleic Acid-based Drugs Revenue Market Share by Type (2025-2030)

Table 31. Global Nucleic Acid-based Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Nucleic Acid-based Drugs Revenue Market Share by Application (2019-2024)

Table 33. Global Nucleic Acid-based Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Nucleic Acid-based Drugs Revenue Market Share by Application (2025-2030)

Table 35. North America Nucleic Acid-based Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Nucleic Acid-based Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Nucleic Acid-based Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Nucleic Acid-based Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Nucleic Acid-based Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Nucleic Acid-based Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Nucleic Acid-based Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Nucleic Acid-based Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Nucleic Acid-based Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Nucleic Acid-based Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Nucleic Acid-based Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Nucleic Acid-based Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Nucleic Acid-based Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Nucleic Acid-based Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Nucleic Acid-based Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 50. Ionis Pharmaceuticals Company Detail

Table 51. Ionis Pharmaceuticals Business Overview

Table 52. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product

Table 53. Ionis Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 54. Ionis Pharmaceuticals Recent Development

Table 55. Sarepta Therapeutics Company Detail

Table 56. Sarepta Therapeutics Business Overview

Table 57. Sarepta Therapeutics Nucleic Acid-based Drugs Product

Table 58. Sarepta Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 59. Sarepta Therapeutics Recent Development

Table 60. Nippon Shinyaku Company Detail

Table 61. Nippon Shinyaku Business Overview

Table 62. Nippon Shinyaku Nucleic Acid-based Drugs Product

Table 63. Nippon Shinyaku Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 64. Nippon Shinyaku Recent Development

Table 65. BioNTech Company Detail

Table 66. BioNTech Business Overview

Table 67. BioNTech Nucleic Acid-based Drugs Product

Table 68. BioNTech Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 69. BioNTech Recent Development

Table 70. Moderna Therapeutics Company Detail

Table 71. Moderna Therapeutics Business Overview

Table 72. Moderna Therapeutics Nucleic Acid-based Drugs Product

Table 73. Moderna Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 74. Moderna Therapeutics Recent Development

Table 75. CureVac Company Detail

Table 76. CureVac Business Overview

Table 77. CureVac Nucleic Acid-based Drugs Product

Table 78. CureVac Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 79. CureVac Recent Development

Table 80. Alnylam Pharmaceuticals Company Detail

Table 81. Alnylam Pharmaceuticals Business Overview

Table 82. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product

Table 83. Alnylam Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 84. Alnylam Pharmaceuticals Recent Development

Table 85. Regulus Therapeutics Company Detail

Table 86. Regulus Therapeutics Business Overview

Table 87. Regulus Therapeutics Nucleic Acid-based Drugs Product

Table 88. Regulus Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 89. Regulus Therapeutics Recent Development

Table 90. Miragen Therapeutics Company Detail

Table 91. Miragen Therapeutics Business Overview

Table 92. Miragen Therapeutics Nucleic Acid-based Drugs Product

Table 93. Miragen Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 94. Miragen Therapeutics Recent Development

Table 95. Mina Therapeutics Company Detail

Table 96. Mina Therapeutics Business Overview

Table 97. Mina Therapeutics Nucleic Acid-based Drugs Product

Table 98. Mina Therapeutics Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 99. Mina Therapeutics Recent Development

Table 100. NeXstar Pharmaceuticals Company Detail

Table 101. NeXstar Pharmaceuticals Business Overview

Table 102. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product

Table 103. NeXstar Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2019-2024) & (US$ Million)

Table 104. NeXstar Pharmaceuticals Recent Development

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Nucleic Acid-based Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Nucleic Acid-based Drugs Market Share by Type: 2023 VS 2030

Figure 3. ASO Features

Figure 4. mRNA Features

Figure 5. siRNA Features

Figure 6. miRNA Features

Figure 7. saRNA Features

Figure 8. Aptamer Features

Figure 9. Global Nucleic Acid-based Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Nucleic Acid-based Drugs Market Share by Application: 2023 VS 2030

Figure 11. Genetic Disease Case Studies

Figure 12. Cancer Case Studies

Figure 13. Cardiovascular Diseases Case Studies

Figure 14. Other Case Studies

Figure 15. Nucleic Acid-based Drugs Report Years Considered

Figure 16. Global Nucleic Acid-based Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Nucleic Acid-based Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Nucleic Acid-based Drugs Market Share by Region: 2023 VS 2030

Figure 19. Global Nucleic Acid-based Drugs Market Share by Players in 2023

Figure 20. Global Top Nucleic Acid-based Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Drugs as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid-based Drugs Revenue in 2023

Figure 22. North America Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Nucleic Acid-based Drugs Market Share by Country (2019-2030)

Figure 24. United States Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Nucleic Acid-based Drugs Market Share by Country (2019-2030)

Figure 28. Germany Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Nucleic Acid-based Drugs Market Share by Region (2019-2030)

Figure 36. China Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Nucleic Acid-based Drugs Market Share by Country (2019-2030)

Figure 44. Mexico Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Nucleic Acid-based Drugs Market Share by Country (2019-2030)

Figure 48. Turkey Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Nucleic Acid-based Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 51. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 52. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 53. BioNTech Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 54. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 55. CureVac Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 57. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 58. Miragen Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 59. Mina Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 60. NeXstar Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Drugs Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Recombinant Human Albumin Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21B1656

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Testing and Analytical Services Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18M9539

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Downstream Processing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14F6057

Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Bioanalytical Services Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z1595

Mon May 20 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions